γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.
复制标题
DOI:
10.1038/s41568-019-0153-5
复制
发表时间:
2019-07
期刊:
影响因子:
--
通讯作者:
Coffelt SB
中科院分区:
文献类型:
--
作者:
Silva-Santos B;Mensurado S;Coffelt SB
The potential of cancer immunotherapy relies on the mobilization of immune cells capable of producing antitumour cytokines and effectively killing tumour cells. These are major attributes of γδ T cells, a lymphoid lineage that is often underestimated despite its major role in tumour immune surveillance, which has been established in a variety of preclinical cancer models. This situation notwithstanding, in particular instances the tumour microenvironment seemingly mobilizes γδ T cells with immunosuppressive or tumour-promoting functions, thus emphasizing the importance of regulating γδ T cell responses in order to realize their translation into effective cancer immunotherapies. In this Review we outline both seminal work and recent advances in our understanding of how γδ T cells participate in tumour immunity and how their functions are regulated in experimental models of cancer. We also discuss the current strategies aimed at maximizing the therapeutic potential of human γδ T cells, on the eve of their exploration in cancer clinical trials that may position them as key players in cancer immunotherapy.
登录
查看更多内容
影响因子:
11.2
作者:
Benevides L;da Fonseca DM;Donate PB;Tiezzi DG;De Carvalho DD;de Andrade JM;Martins GA;Silva JS
通讯作者:
Silva JS
影响因子:
7.2
作者:
Correia DV;Lopes A;Silva-Santos B
通讯作者:
Silva-Santos B
影响因子:
30.5
作者:
Crawford G;Hayes MD;Seoane RC;Ward S;Dalessandri T;Lai C;Healy E;Kipling D;Proby C;Moyes C;Green K;Best K;Haniffa M;Botto M;Dunn-Walters D;Strid J
通讯作者:
Strid J
影响因子:
5.8
作者:
Altvater, Bianca;Pscherer, Sibylle;Rossig, Claudia
通讯作者:
Rossig, Claudia
影响因子:
7.3
作者:
Bhat SA;Vedpathak DM;Chiplunkar SV
通讯作者:
Chiplunkar SV